Peter Lutwyche
Director/Miembro de la Junta en Renaissance BioScience Corp. .
Origen de la red de primer grado Peter Lutwyche.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
39
| Extinct | Miscellaneous Commercial Services | 39 |
| Public Company | Pharmaceuticals: Major | 37 | |
Renaissance BioScience Corp.
 Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation.
5
| Private Company | Miscellaneous Commercial Services | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Peter Lutwyche a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Operating Officer Sales & Marketing | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer General Counsel | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Human Resources Officer | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member Founder Chief Executive Officer | |
| University of Oxford | College/University | Doctorate Degree Masters Business Admin | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Public Communications Contact Human Resources Officer | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| Queen's University | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
| Indiana University | College/University | Doctorate Degree Doctorate Degree | |
| University of Alberta | College/University | Doctorate Degree Doctorate Degree | |
| University of British Columbia | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| Simon Fraser University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree | |
| University of Victoria | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Johnson Graduate School of Management | College/University | Masters Business Admin Masters Business Admin | |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| Alberta Bar Association | Corporate Officer/Principal Corporate Officer/Principal | ||
Genome British Columbia
 Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Eutropics Pharmaceuticals, Inc.
 Eutropics Pharmaceuticals, Inc. Internet Software/ServicesTechnology Services Eutropics Pharmaceuticals, Inc. operates as a biomarker technology platform for accelerating drug discovery and development. The private company is based in Cambridge, MA. The company was founded in 2005 by Gary E. Frashier, Michael Cardone. Michael Cardone has been the CEO since 2005. | Internet Software/Services | Founder Chief Operating Officer | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Public Communications Contact Human Resources Officer | |
Valocor Therapeutics, Inc.
 Valocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Valocor Therapeutics is a clinical-stage, privately-held company dedicated to developing innovative treatments for major unmet needs in dermatology. The company's portfolio of dermatology therapeutics includes Lemuteporfin, a potent and selective topical photodynamic therapy for moderate to severe acne and a portfolio of novel, topical small molecule therapeutics targeting acne, sebaceous gland hyperactivity, skin pigmentation disorders and inflammatory skin diseases. Valocor Therapeutics is headquartered in Vancouver, British Columbia. Although many common yet serious skin conditions have unsatisfactory treatment options, dermatology has in recent years attracted limited research resources and investment. As a result, a sparse pipeline and a lack of true scientific innovation have been the dominant themes of this field for the last twenty years. During this same period, technological advances have produced new research techniques that have greatly expanded its ability to study disease processes and establish new effective therapeutic strategies. Much of this innovative research has been applied to the fields such as oncology, autoimmunity, and ocular diseases. Valocor is applying current biotechnology techniques to develop breakthrough therapies for major dermatological diseases, where prevalent conditions, minimal competition and important medical needs exist. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO Director/Board Member Chairman | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Founder Chairman Director/Board Member Founder |
Estadísticas
Internacional
| Canadá | 28 |
| Estados Unidos | 22 |
| Reino Unido | 3 |
Sectorial
| Health Technology | 29 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Health Services | 2 |
| Technology Services | 2 |
Operativa
| Director/Board Member | 355 |
| Corporate Officer/Principal | 169 |
| Independent Dir/Board Member | 91 |
| President | 82 |
| Chairman | 80 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Alan C. Mendelson | 45 |
| Philip B. Livingston | 31 |
| Ken Galbraith | 30 |
| Dan Kisner | 29 |
| Daniel Burgess | 28 |
| R. MacKay-Dunn | 26 |
| Gary E. Frashier | 26 |
| Bruce Carter | 25 |
| Paul Hastings | 25 |
| Julia G. Levy | 22 |
| Ronald Ian Lennox | 22 |
| Victor Stanley Dusik | 21 |
| Mohammad Azab | 21 |
| Blair Jordan | 19 |
| Richard R. Vietor | 17 |
- Bolsa de valores
- Insiders
- Peter Lutwyche
- Conexiones Empresas
